vs

Side-by-side financial comparison of BELDEN INC. (BDC) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

BELDEN INC. is the larger business by last-quarter revenue ($720.1M vs $487.7M, roughly 1.5× CLOVER HEALTH INVESTMENTS, CORP.). BELDEN INC. runs the higher net margin — 9.4% vs -10.1%, a 19.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 8.1%). BELDEN INC. produced more free cash flow last quarter ($121.3M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 15.9%).

Belden Inc. is an American, multinational, publicly traded company specializing in the design, manufacture, and distribution of end-to-end networking, security and connectivity products. The company serves the Industrial Automation Solutions, Smart Buildings and Broadband & 5G markets.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

BDC vs CLOV — Head-to-Head

Bigger by revenue
BDC
BDC
1.5× larger
BDC
$720.1M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+36.6% gap
CLOV
44.7%
8.1%
BDC
Higher net margin
BDC
BDC
19.5% more per $
BDC
9.4%
-10.1%
CLOV
More free cash flow
BDC
BDC
$190.2M more FCF
BDC
$121.3M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
15.9%
BDC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BDC
BDC
CLOV
CLOV
Revenue
$720.1M
$487.7M
Net Profit
$67.9M
$-49.3M
Gross Margin
36.6%
Operating Margin
12.2%
-10.1%
Net Margin
9.4%
-10.1%
Revenue YoY
8.1%
44.7%
Net Profit YoY
16.3%
-123.2%
EPS (diluted)
$1.70

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDC
BDC
CLOV
CLOV
Q4 25
$720.1M
$487.7M
Q3 25
$698.2M
$496.6M
Q2 25
$672.0M
$477.6M
Q1 25
$624.9M
$462.3M
Q4 24
$666.0M
$337.0M
Q3 24
$654.9M
$331.0M
Q2 24
$604.3M
$356.3M
Q1 24
$535.7M
$346.9M
Net Profit
BDC
BDC
CLOV
CLOV
Q4 25
$67.9M
$-49.3M
Q3 25
$56.7M
$-24.4M
Q2 25
$61.0M
$-10.6M
Q1 25
$51.9M
$-1.3M
Q4 24
$58.4M
$-22.1M
Q3 24
$53.7M
$-9.2M
Q2 24
$49.0M
$7.4M
Q1 24
$37.3M
$-19.2M
Gross Margin
BDC
BDC
CLOV
CLOV
Q4 25
36.6%
Q3 25
37.7%
Q2 25
38.5%
Q1 25
39.3%
Q4 24
37.5%
Q3 24
37.3%
24.5%
Q2 24
37.5%
30.3%
Q1 24
37.6%
23.6%
Operating Margin
BDC
BDC
CLOV
CLOV
Q4 25
12.2%
-10.1%
Q3 25
10.9%
-4.9%
Q2 25
11.8%
-2.2%
Q1 25
11.6%
-0.3%
Q4 24
10.4%
-6.4%
Q3 24
11.5%
-2.7%
Q2 24
11.4%
2.0%
Q1 24
9.9%
-6.5%
Net Margin
BDC
BDC
CLOV
CLOV
Q4 25
9.4%
-10.1%
Q3 25
8.1%
-4.9%
Q2 25
9.1%
-2.2%
Q1 25
8.3%
-0.3%
Q4 24
8.8%
-6.6%
Q3 24
8.2%
-2.8%
Q2 24
8.1%
2.1%
Q1 24
7.0%
-5.5%
EPS (diluted)
BDC
BDC
CLOV
CLOV
Q4 25
$1.70
Q3 25
$1.41
Q2 25
$1.53
Q1 25
$1.27
Q4 24
$1.41
Q3 24
$1.30
Q2 24
$1.19
Q1 24
$0.90

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDC
BDC
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$389.9M
$78.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$308.7M
Total Assets
$3.5B
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDC
BDC
CLOV
CLOV
Q4 25
$389.9M
$78.3M
Q3 25
$314.3M
Q2 25
$301.5M
Q1 25
$259.0M
Q4 24
$370.3M
$194.5M
Q3 24
$323.0M
$288.0M
Q2 24
$564.8M
$254.8M
Q1 24
$506.8M
$208.3M
Stockholders' Equity
BDC
BDC
CLOV
CLOV
Q4 25
$1.3B
$308.7M
Q3 25
$1.2B
$340.9M
Q2 25
$1.2B
$344.2M
Q1 25
$1.2B
$336.1M
Q4 24
$1.3B
$341.1M
Q3 24
$1.2B
$342.2M
Q2 24
$1.2B
$324.9M
Q1 24
$1.2B
$292.5M
Total Assets
BDC
BDC
CLOV
CLOV
Q4 25
$3.5B
$541.0M
Q3 25
$3.4B
$559.7M
Q2 25
$3.4B
$575.0M
Q1 25
$3.3B
$583.7M
Q4 24
$3.3B
$580.7M
Q3 24
$3.3B
$653.0M
Q2 24
$3.5B
$674.2M
Q1 24
$3.1B
$671.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDC
BDC
CLOV
CLOV
Operating Cash FlowLast quarter
$160.4M
$-66.9M
Free Cash FlowOCF − Capex
$121.3M
$-69.0M
FCF MarginFCF / Revenue
16.8%
-14.1%
Capex IntensityCapex / Revenue
5.4%
0.4%
Cash ConversionOCF / Net Profit
2.36×
TTM Free Cash FlowTrailing 4 quarters
$218.7M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDC
BDC
CLOV
CLOV
Q4 25
$160.4M
$-66.9M
Q3 25
$105.0M
$12.1M
Q2 25
$82.0M
$5.4M
Q1 25
$7.4M
$-16.3M
Q4 24
$174.7M
$34.8M
Q3 24
$91.7M
$50.0M
Q2 24
$83.0M
$44.8M
Q1 24
$2.7M
$25.9M
Free Cash Flow
BDC
BDC
CLOV
CLOV
Q4 25
$121.3M
$-69.0M
Q3 25
$65.3M
$11.4M
Q2 25
$56.9M
$4.8M
Q1 25
$-24.8M
$-16.5M
Q4 24
$116.4M
$33.3M
Q3 24
$67.2M
$49.6M
Q2 24
$61.0M
$44.4M
Q1 24
$-21.5M
$25.5M
FCF Margin
BDC
BDC
CLOV
CLOV
Q4 25
16.8%
-14.1%
Q3 25
9.4%
2.3%
Q2 25
8.5%
1.0%
Q1 25
-4.0%
-3.6%
Q4 24
17.5%
9.9%
Q3 24
10.3%
15.0%
Q2 24
10.1%
12.5%
Q1 24
-4.0%
7.3%
Capex Intensity
BDC
BDC
CLOV
CLOV
Q4 25
5.4%
0.4%
Q3 25
5.7%
0.1%
Q2 25
3.7%
0.1%
Q1 25
5.2%
0.0%
Q4 24
8.8%
0.5%
Q3 24
3.7%
0.1%
Q2 24
3.6%
0.1%
Q1 24
4.5%
0.1%
Cash Conversion
BDC
BDC
CLOV
CLOV
Q4 25
2.36×
Q3 25
1.85×
Q2 25
1.34×
Q1 25
0.14×
Q4 24
2.99×
Q3 24
1.71×
Q2 24
1.69×
6.04×
Q1 24
0.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDC
BDC

Automation Solutions Segment$397.7M55%
Broadband Solutions$164.8M23%
Smart Buildings Solutions$157.7M22%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons